18Feb/14

Studies of cow antibodies help scientists understand how our own bodies work – Medical Xpress

February 18, 2014Antibodiesadmin

Studies of cow antibodies help scientists understand how our own bodies work
Medical Xpress
This image shows the crystal structure of bovine antibody BLV1H12 with the exceptionally large, “ball-and-chain” antigen binding domain depicted as red ribbons. The core domains of the heavy and light chains are colored pink and cyan, respectively …
Cows moove our understanding of the immune systemScience Codex

all 5 news articles »

18Feb/14

Advaxis, Inc. – "Advaxis Immunotherapies Complement PD-1 Antibodies" – MarketWatch

February 18, 2014Antibodiesadmin

Advaxis, Inc. – “Advaxis Immunotherapies Complement PD-1 Antibodies“
MarketWatch
Feb 18, 2014 (ACCESSWIRE via COMTEX) — Advaxis Inc. (NASDAQ:ADXS) today published a new blog post on The Chairman’s Blog, written by the company’s CSO, Dr. Robert Petit. TheChairmansBlog.com is an exclusive online media publication that …
Advaxis, Inc. – “Advaxis Immunotherapies Complement PD-1 Antibodies”Baystreet.ca

all 9 news articles »

18Feb/14

The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells … – MarketWatch

February 18, 2014Antibodiesadmin

The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells …MarketWatchLONDON, Feb. 18, 2014 /PRNewswire/ — Reportbuyer.com just published a new market research report: The Engineered T-Cell Receptor in Fusion Proteins, Antibodies &am…

18Feb/14

Rituximab not be beneficial long-term in Sjorgen's Syndrome – 2 Minute Medicine

February 18, 2014Monoclonal Anti-CD20 Antibodiesadmin

Rituximab not be beneficial long-term in Sjorgen’s Syndrome
2 Minute Medicine
1. The results of this study suggest that rituximab (Rituxin) treatment is not associated with a significant improvement in symptoms or disease activity at 6 months for patients with primary Sjogren syndrome (pSS). 2. There were transient improvements …

17Feb/14

Annals of Internal Medicine tip sheet for Feb. 18, 2014 – Science Codex

February 17, 2014Monoclonal Anti-CD20 Antibodiesadmin

Annals of Internal Medicine tip sheet for Feb. 18, 2014Science CodexRituximab is an anti-CD20 antibody. Researchers conducted a multicenter, double-blind, placebo-controlled, randomized trial to evaluate the efficacy and harms of rituximab in adults wi…

17Feb/14

Relief from Sjögren's? Not With This Arthritis Rx – dailyRx

February 17, 2014Monoclonal Anti-CD20 Antibodiesadmin

Relief from Sjögren’s? Not With This Arthritis Rx
dailyRx
The researchers concluded that rituximab was not tied to significant improvements in symptoms of primary Sjögren’s syndrome after 24 weeks. However, the medication did lead to improvements at week six, suggesting that it may have short-term …

17Feb/14

Major antibodies producer mistreated animals, feds say – UPI.com (blog)

February 17, 2014Antibodiesadmin

UPI.com (blog)

Major antibodies producer mistreated animals, feds say
UPI.com (blog)
17 (UPI) — Santa Cruz Biotechnology is the second largest supplier of antibodies in the world. It’s also been repeatedly mistreating animals, the USDA claims. The agency recently filed a formal complaint against the company outlining a variety of abuses.
Antibody Maker Headed to CourtScientist

all 2 news articles »

17Feb/14

APS: More than Just a Thrombophilia – Pharmacy Times

February 17, 2014Monoclonal Anti-CD20 Antibodiesadmin

APS: More than Just a Thrombophilia
Pharmacy Times
Some nonanticoagulant treatment options include the use of HMG Co-A reductase inhibitors (ie, “statins”) and rituximab. Statins potentially have a role in treating APS due to their anti-inflammatory, anticoagulant, and immunoregulatory effects …

17Feb/14

Research and Markets: Competitor Analysis: VEGF Antibodies – Bevacizumab … – Business Wire (press release)

February 17, 2014Antibodiesadmin

Research and Markets: Competitor Analysis: VEGF Antibodies – Bevacizumab …Business Wire (press release)The present Competitive Intelligence Report about VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors provides a competitor …

17Feb/14

Research and Markets: Competitor Analysis: CD20 Antibodies – Rituximab … – Fort Mills Times

February 17, 2014Monoclonal Anti-CD20 Antibodiesadmin

Research and Markets: Competitor Analysis: CD20 Antibodies – Rituximab …Fort Mills TimesThe present Competitive Intelligence Report about CD20 Antibodies – Rituximab Biosimilars and Biobetters/Biosuperiors provides a competitor evaluation in the fiel…

Category Archives: Antibodies